Fatty liver disease (MASLD/MASH) trials in Chile

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Where

  La Serena, Santiago, Viña del Mar

  Age

  18 years and over

  People

  1,800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632444 · EU 2024-513739-25-00
• Phase 3Taking people
  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Where

  La Serena, Santiago, Viña del Mar

  Age

  18 years and over

  People

  1,590 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632457 · EU 2024-513741-36-00
• Phase 3Taking people
  A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  Where

  Las Condes, La Serena, Santiago

  Age

  18 years to 80 years

  People

  2,150 worldwide

  Run by

  Akero Therapeutics, Inc

  See details and how to joinNCT06528314
• No phaseTaking people
  Prevention of NAFLD and CVD Through Lifestyle Intervention

  Where

  Molina

  Age

  45 years to 60 years

  People

  300

  Run by

  Pontificia Universidad Catolica de Chile

  See details and how to joinNCT05618626